1 research outputs found
Π¦-ΡΠ΅Π°ΠΊΡΠΈΠ²Π΅Π½ ΠΏΡΠΎΡΠ΅ΠΈΠ½ ΠΈ cΠΎΠΎΠ΄Π½ΠΎΡΠΎΡ Π½Π° Π½Π΅ΡΡΡΠΎΡΠΈΠ»ΠΈ-Π»ΠΈΠΌΡΠΎΡΠΈΡΠΈ ΠΊΠ°ΠΊΠΎ ΡΠ°ΠΊΡΠΎΡΠΈ Π·Π° ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΈΠ²Π½ΠΎΡΡ Π½Π° ΡΠ΅ΠΆΠΈΠ½Π°ΡΠ° Π½Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠΊΠ°ΡΠ° ΡΠ»ΠΈΠΊΠ° ΠΊΠ°Ρ COVID-19
COVID-19 is an infectious disease that can manifest quite differently. In this study we examined the relationship between the value of serum CRP(C-reactive protein) andneutrophil-lymphocyte ratio (NLR) as predictor factors for the development of a severe clinical manifestation in COVID19 patients. Materials and methods: We followed 95 COVID-19 positive patients who were hospitalized at the University Clinic for Eye Diseases - COVID Center. We analyzed the initial laboratory parameters of white blood cells and CRP on admission of the patients and the results of laboratory analyses performed before they left the Clinic, or the last parameters before the lethal outcome in those patients who died. Several models of logistic regression were tested to analyze the predictive value of these markers of inflammation for lethal outcome in patients hospitalized for COVID-19. Results: Bivariate analysis demonstrated that the length of hospital stay was significantly shorter in patients with lethal outcome (p=0.001). The NLR was significantly higher in patients with lethal outcome at both times (p=0.005; and p=0.017). Leukocyteβs count (p=0.046, and p<0.001) and CRP (p=0.013,and p=0.005) were also significantly higher in patients with lethal outcome at both times. The increase on the NLR scale both at hospitalization and at discharge (or the last analysis before death) leads to increase in the odds of lethal outcome (T1:40.4% increased odds; T2:36% increased odds). Conclusion: CRP and NLR are laboratory parameters that can predict the severity of the clinical manifestation in patients with COVID-19.COVID-19 Π΅ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎ Π·Π°Π±ΠΎΠ»ΡΠ²Π°ΡΠ΅ ΠΊΠΎΠ΅ ΠΌΠΎΠΆΠ΅ Π΄Π° ΡΠ΅ ΠΌΠ°Π½ΠΈΡΠ΅ΡΡΠΈΡΠ° Π΄ΠΎΡΡΠ° ΡΠ°Π·Π»ΠΈΡΠ½ΠΎ. ΠΠΎ ΠΎΠ²Π°Π° ΡΡΡΠ΄ΠΈΡΠ° Π½ΠΈΠ΅ ΡΠ° ΠΈΡΠΏΠΈΡΡΠ²Π°Π²ΠΌΠ΅ ΠΏΠΎΠ²ΡΠ·Π°Π½ΠΎΡΡΠ° ΠΏΠΎΠΌΠ΅ΡΡ Π²ΡΠ΅Π΄Π½ΠΎΡΡΠΈΡΠ΅ Π½Π° CRP (Π¦-ΡΠ΅Π°ΠΊΡΠΈΠ²Π΅Π½ ΠΏΡΠΎΡΠ΅ΠΈΠ½) ΠΈ ΡΠΎΠΎΠ΄Π½ΠΎΡΠΎΡ Π½Π΅ΡΡΡΠΎΡΠΈΠ»ΠΈ-Π»ΠΈΠΌΡΠΎΡΠΈΡΠΈ (NLR) ΠΊΠ°ΠΊΠΎ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΈΠ²Π½ΠΈ ΡΠ°ΠΊΡΠΎΡΠΈ Π·Π° ΡΠ°Π·Π²ΠΎΡ Π½Π° ΡΠ΅ΡΠΊΠ° ΠΊΠ»ΠΈΠ½ΠΈΡΠΊΠ° ΡΠ»ΠΈΠΊΠ° ΠΊΠ°Ρ ΠΏΠ°ΡΠ΅Π½ΡΠΈΡΠ΅ ΡΠΎ COVID-19. ΠΠ°ΡΠ΅ΡΠΈΡΠ°Π»ΠΈ ΠΈ ΠΌΠ΅ΡΠΎΠ΄ΠΈ:Π‘Π»Π΅Π΄Π΅Π²ΠΌΠ΅ 95 COVID-19 ΠΏΠΎΠ·ΠΈΡΠΈΠ²Π½ΠΈ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ ΠΊΠΎΠΈ Π±Π΅Π° Ρ
ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·ΠΈΡΠ°Π½ΠΈ Π²ΠΎ Π£Π Π·Π° ΠΎΡΠ½ΠΈ Π±ΠΎΠ»Π΅ΡΡΠΈ - COVID ΡΠ΅Π½ΡΠ°Ρ Π²ΠΎ Π‘ΠΊΠΎΠΏΡΠ΅. ΠΠΈ Π°Π½Π°Π»ΠΈΠ·ΠΈΡΠ°Π²ΠΌΠ΅ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠΈΡΠΊΠΈΡΠ΅ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΈ Π½Π° Π»Π΅ΡΠΊΠΎΡΠΈΡΠΈΡΠ΅ ΠΈ CRP ΠΏΡΠΈ ΠΏΡΠΈΠ΅ΠΌ Π½Π° ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈΡΠ΅ Π²ΠΎ ΠΠ»ΠΈΠ½ΠΈΠΊΠ°ΡΠ° ΠΈ ΡΠ΅Π·ΡΠ»ΡΠ°ΡΠΈΡΠ΅ ΠΎΠ΄ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠΈΡΠΊΠΈΡΠ΅ Π°Π½Π°Π»ΠΈΠ·ΠΈ ΠΈΠ·Π²Π΅Π΄Π΅Π½ΠΈ ΠΏΡΠ΅Π΄ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈΡΠ΅ Π΄Π° ΡΠ° Π½Π°ΠΏΡΡΡΠ°Ρ ΠΠ»ΠΈΠ½ΠΈΠΊΠ°ΡΠ° ΠΈΠ»ΠΈ ΠΏΡΠ΅Π΄ Π½ΠΈΠ²Π½ΠΈΠΎΡ Π»Π΅ΡΠ°Π»Π΅Π½ ΠΈΡΡ
ΠΎΠ΄, ΠΊΠ°Ρ ΠΎΠ½ΠΈΠ΅ ΡΡΠΎ ΠΏΠΎΡΠΈΠ½Π°Π°. ΠΠ΅Π° ΡΠ΅ΡΡΠΈΡΠ°Π½ΠΈ Π½Π΅ΠΊΠΎΠ»ΠΊΡ ΠΌΠΎΠ΄Π΅Π»ΠΈ Π½Π° Π»ΠΎΠ³ΠΈΡΡΠΈΡΠΊΠ° ΡΠ΅Π³ΡΠ΅ΡΠΈΡΠ° ΡΠΎ ΡΠ΅Π» Π΄Π° ΡΠ΅ ΡΡΠ²ΡΠ΄ΠΈ ΠΏΡΠ΅Π΄ΠΈΠΊΡΠΈΠ²Π½Π°ΡΠ° Π²ΡΠ΅Π΄Π½ΠΎΡΡ Π½Π° ΠΎΠ²ΠΈΠ΅ ΠΌΠ°ΡΠΊΠ΅ΡΠΈ Π½Π° ΠΈΠ½ΡΠ»Π°ΠΌΠ°ΡΠΈΡΠ° Π·Π° Π»Π΅ΡΠ°Π»Π΅Π½ ΠΈΡΡ
ΠΎΠ΄ ΠΊΠ°Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ Ρ
ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·ΠΈΡΠ°Π½ΠΈ ΠΎΠ΄ COVID-19. Π Π΅Π·ΡΠ»ΡΠ°ΡΠΈ: ΠΠ½Π°Π»ΠΈΠ·Π°ΡΠ° ΠΏΠΎΠΊΠ°ΠΆΠ° Π΄Π΅ΠΊΠ° Π΄ΠΎΠ»ΠΆΠΈΠ½Π°ΡΠ° Π½Π° ΠΏΡΠ΅ΡΡΠΎΡ Π²ΠΎ Π±ΠΎΠ»Π½ΠΈΡΠ° Π±Π΅ΡΠ΅ Π·Π½Π°ΡΠΈΡΠ΅Π»Π½ΠΎ ΠΏΠΎΠΊΡΠ°ΡΠΊΠ° ΠΊΠ°Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈΡΠ΅ ΡΠΎ Π»Π΅ΡΠ°Π»Π΅Π½ ΠΈΡΡ
ΠΎΠ΄ (=0,001). NLR Π±Π΅ΡΠ΅ Π·Π½Π°ΡΠΈΡΠ΅Π»Π½ΠΎ ΠΏΠΎΠ²ΠΈΡΠΎΠΊ ΠΊΠ°Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ ΡΠΎ Π»Π΅ΡΠ°Π»Π΅Π½ ΠΈΡΡ
ΠΎΠ΄ ΠΈ Π²ΠΎ Π΄Π²Π΅ΡΠ΅ Π²ΡΠ΅ΠΌΠΈΡΠ° (p = 0,005; ΠΈ p = 0,017). ΠΡΠΎΡΠΎΡ Π½Π° Π»Π΅ΡΠΊΠΎΡΠΈΡΠΈΡΠ΅ (p = 0,046, ΠΈ p <0.001) ΠΈ CRP (p = 0,013, ΠΈ p = 0,005), ΠΈΡΡΠΎ ΡΠ°ΠΊΠ°, Π±Π΅Π° Π·Π½Π°ΡΠΈΡΠ΅Π»Π½ΠΎ ΠΏΠΎΠ²ΠΈΡΠΎΠΊΠΈ ΠΊΠ°Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ ΡΠΎ Π»Π΅ΡΠ°Π»Π΅Π½ ΠΈΡΡ
ΠΎΠ΄ Π²ΠΎ Π΄Π²Π΅ΡΠ΅ Π²ΡΠ΅ΠΌΠΈΡΠ°. ΠΠΎΠ²ΠΈΡΠΎΠΊΠΈ Π²ΡΠ΅Π΄Π½ΠΎΡΡΠΈ Π½Π° NLR ΠΈ ΠΏΡΠΈ Ρ
ΠΎΡΠΏΠΈΡΠ°Π»ΠΈΠ·Π°ΡΠΈΡΠ° ΠΈ ΠΏΡΠΈ ΠΎΡΠΏΡΡΡΠ°ΡΠ΅ (ΠΈΠ»ΠΈ ΠΏΠΎΡΠ»Π΅Π΄Π½Π° Π°Π½Π°Π»ΠΈΠ·Π° ΠΏΡΠ΅Π΄ Π½Π°ΡΡΠ°ΠΏΡΠ²Π°ΡΠ΅ Π½Π° ΡΠΌΡΡΡΠ°) Π΄ΠΎΠ²Π΅Π΄ΡΠ²Π° Π΄ΠΎ Π·Π³ΠΎΠ»Π΅ΠΌΡΠ²Π°ΡΠ΅ Π½Π° ΡΠ°Π½ΡΠΈΡΠ΅ Π·Π° Π»Π΅ΡΠ°Π»Π΅Π½ ΠΈΡΡ
ΠΎΠ΄ (Π’1: 40,4% Π·Π³ΠΎΠ»Π΅ΠΌΠ΅Π½ΠΈ ΡΠ°Π½ΡΠΈ; Π’2: 36% Π·Π³ΠΎΠ»Π΅ΠΌΠ΅Π½ΠΈ ΡΠ°Π½ΡΠΈ). ΠΠ°ΠΊΠ»ΡΡΠΎΠΊ: CRP ΠΈ NLR ΡΠ΅ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠΈΡΠΊΠΈ ΠΏΠ°ΡΠ°ΠΌΠ΅ΡΡΠΈ ΠΊΠΎΠΈ ΠΌΠΎΠΆΠ°Ρ Π΄Π° ΡΠ° ΠΏΡΠ΅Π΄Π²ΠΈΠ΄Π°Ρ ΡΠ΅ΡΠΈΠΎΠ·Π½ΠΎΡΡΠ° Π½Π° ΠΊΠ»ΠΈΠ½ΠΈΡΠΊΠ°ΡΠ° ΡΠ»ΠΈΠΊΠ° ΠΊΠ°Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΈ ΡΠΎ COVID-19.